Pricing Log in Create free account

Context Therapeutics Inc. (CNTX) vs Celyad SA (CYAD)

Context Therapeutics Inc. and Celyad SA are both Biotechnology companies. Context Therapeutics Inc. and Celyad SA are of similar size ($23.8M and $22.1M). Across the 8 metrics below, Context Therapeutics Inc. leads on 4 and Celyad SA on 4.

Valuation

Metric CNTX CYAD Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.60 11.18 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.41 — 0.64
EV/Sales n/m — 9.21
Earnings yield (200.00%) (708.87%) (33.15%)
Free cash flow yield (148.95%) (438.06%) (25.50%)

Profitability

Metric CNTX CYAD Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.14%) 0.00% (56.36%)
Return on assets (68.96%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNTX CYAD Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 17.39% 113.33% 30.26%
Revenue growth, 5-year CAGR — (63.51%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTX CYAD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.81 0.94 4.72
Net debt to EBITDA 1.66 (1.62) 0.96

Dividend

Metric CNTX CYAD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNTX CYAD Biotechnology median
Market cap 22.09m 23.79m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack